GEOS vs GSK · rev $110.8M vs P/E 13, $103.31B cap
Geospace Technologies Corporation (GEOS) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Geospace Technologies Corporation (GEOS) is a oil & gas equipment & services company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported GEOS revenue for 2025-09-30 was $110.8M. Net income was -$9.7M. GEOS currently screens at market cap $160.9M.
GSK does not have a complete income-statement cache yet.
GEOS currently screens at market cap $160.9M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the GEOS and GSK stock pages for the full models.
Not investment advice.